Based on the findings obtained from the CCK-8 assay, it was observed that the inhibition of HOXD10 effectively mitigated the 24 and 48 h suppression of glioma cell proliferation induced by gastrodin (Figure 6A). Here, HOXD10 is linked to central nervous system cancer.